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Background: Studies have demonstrated that inflammation has a key role in the pathogenesis of atherosclerosis
due to the abnormal gene expressions of multiple cytokines. We established an accurate and precise method to
observe gene expression in whole blood that might provide specific diagnostic information for coronary artery
disease (CAD) and other related diseases.
Methods: The fifteen selected CAD-related genes (IL1B, IL6, IL8, IFNG, MCP-1, VWF, MTHFR, SELL, TNFalpha,
ubiquitin, MCSF, ICAM1, ID2, HMOX1 and LDLR) and two housekeeping genes (ACTB and GK) as internal references
have been measured simultaneously with a newly developed multiplex polymerase chain reaction (multi-PCR)
method. Moreover, the precision was evaluated, and a procedure for distinguishing patients from the normal
population has been developed based upon analyses of peripheral blood. A total of 148 subjects were divided into
group A (control group without plaques), group B (calcified plaques) and group C (non-calcified plaques, and
combination group) according dual-source CT criteria. Gene expression in blood was analyzed by multi-PCR, and
levels of glucose and lipids measured in 50 subjects to explore the relationship among them.
Results: The precision results of the multi-PCR system revealed within-run and between-run CV values of
3.695–12.537% and 4.405–13.405%, respectively. The profiles of cytokine gene expression in peripheral blood were
set: a positive correlation between glucose and MCSF, HMOX1 or TNFalpha were found. We also found that
triglyceride levels were negatively correlated with SELL gene expression in 50 subjects. Compared with controls,
gene expression levels of IL1B, IL6, IL8 and MCP-1 increased significantly in group C.
Conclusions: A new multiple gene expression analysis system has been developed. The primary data suggested that
gene expression was related to CAD. This system might be used for risk assessment of CVDs and other related diseases.
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Coronary artery disease (CAD) is the main cause of
death in adults in western countries [1]. During the past
two decades, with changes in lifestyle and urbanization,
the morbidity of CAD has increased gradually in China
[2], and most subjects do not have symptoms before a
cardiac event. Early recognition of the risk of athero-
sclerosis is important for the prevention of cardiac dis-
ease, as is early intervention in individuals at high risk of* Correspondence: tianyp61@gmail.com
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reproduction in any medium, provided the orCAD. Nowadays, little information is available on early
gene expression in subjects at high risk for CAD but
who do not exhibit symptoms.
Evidence suggests that many acute coronary syn-
dromes are caused by plaque disruption and thrombosis
rather than stenosis severity [3]. The composition and
configuration of atherosclerotic plaques are the main
factors for plaque stability [4]. Conventional angiog-
raphy, intravascular ultrasound (IVUS) and optical co-
herence tomography (OCT) are invasive or lack
precision [5]. Multislice computed tomography (MSCT)
is a new chapter in non-invasive assessment of athero-
sclerotic plaques, but its usage is restricted because ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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invasive detection method is urgently needed in subjects
who have risk factors for CAD. Peripheral blood is an
accessible source compared with other tissues. More-
over, blood contains platelets, neutrophils and circulat-
ing leukocytes that are associated with processes in
cardiovascular diseases (CVDs) [7]. Thus, gene expres-
sion profiling in peripheral blood could provide informa-
tion on early risk factors for CVDs [8].
In recent years, studies have demonstrated that inflam-
mation has a key role in the pathogenesis of atheroscler-
osis [9-11]. Multiple cytokines such as interleukin IL1B,
IL6, IL8, IL10, IFNG, MCP-1, TNFalpha, MCSF, and
ICAM1 are present at inflammation sites, each of which
participate in the processes of atherosclerotic plaques
[12-14]. Furthermore, TNFalpha, IL1B and IFNG pro-
mote the instability or disruption of atherosclerotic pla-
ques [15]. Besides these inflammation-related cytokines,
other gene expression panels such as HMOX1, VWF,
ID2, MTHFR and SELL (which are also involved in the
development and progression of atherosclerosis) are of
great interest to researchers. However, almost all of such
studies have focused on individual gene expression,
which cannot provide the profile information of all
inflammation-related cytokines [16-21].
Instead of the analyses of single genes described above,
technologies such as cDNA microarrays can analyze thou-
sand of transcripts in one chip [22]. However, it is expen-
sive, has low sample throughput, and standardized
procedures for optimization of the signal/noise ratio are
lacking [23]. Beckman Coulter (Fullerton, CA, USA)
developed the GenomeLab GeXP (Gene Expression Pro-
filer) Genetic Analysis System that can be used to analyze
up to 35 genes in a single reaction. Also, 192 samples can
be evaluated simultaneously in a single analysis [24].
We carried out analytical validation of the GeXP sys-
tem in blood samples. We were interested in establishing
a platform for 15 CVD-related gene expression profiles
and 2 housekeeping genes. The optimization process is
described here.
Methods
The study protocol was approved by the Medical Ethics
Committee of the Chinese PLA General Hospital
(Beijing, China). All subjects provided written informed
consent to be included in the study.
Patients and controls
According to the imaging characteristics of dual-source
CT, subjects were divided into group A (control group
without plaques), group B (calcified plaques) and group
C (non-calcified plaques, and combination group). With
respect to the classification criteria for the plaques, non-
calcified plaques showed a density <150 Hounsfieldunits (HU) [25], whereas calcified plaques showed a
density >300 HU [25, 26]. The characteristics of the
study subjects are shown in Additional file 1: Table 1.
Sample collection and RNA extraction
Samples of peripheral blood were collected in ethylenedi-
amine tetra-acetic acid (EDTA) vacutainer tubes (VACA-
ETTE, Greiner, Austria). Ribonucleic Acid (RNA) was
extracted within 6 h. One milliliter of whole blood was
transferred to a new tube and 3 mL of Cell Lysis Solution
(Promega, Fitchburg, WI, USA) was added to lyse red
blood cells (RBC). The mixture was allowed to stand at
room temperature for 10 min and was then centrifuged at
3,000 rpm for 3 min. Depositions were washed by isotonic
NaCl and 1 mL of TRIzol reagent (Invitrogen, Carlsbad,
CA, USA) added. After thorough mixing, 200 μL of
chloroform was added. It was then centrifuged at
15,000 rpm for 10 min at room temperature. The upper
aqueous phase was transferred to a 1.5-mL Eppendorf
(Hamburg, Germany) tube and an equal volume of isopro-
panol added to precipitate RNA. The RNA pellet was
resuspended in diethyl pyrocarbonate-treated water after
it was washed with 75% ethanol and air-dried. Residual
DNA was digested by Dnase (Promega). Finally, the total
RNA concentration was quantified using a ultraviolet
(UV) Spectrophotometer (Beckman Coulter) and RNA in-
tegrity checked by 1% agarose gel electrophoresis.
Design of GeXPS primer
The multiplex primers were designed using Gexp ex-
press Profiler software (Beckman Coulter) (Additional
file 2: Table 2). Each reverse primer contained a 19-
nucleotide universal priming sequence at the 5′ end, and
the 3′ end contained 20 nucleotides that were comple-
mentary to the target gene. Each forward primer con-
sisted of a 18-nucleotide universal priming sequence at
the 5′ end, and the 3′ end contained 20 nucleotides
that corresponded to the target gene. Inside the Gexp
PCR buffer were two pairs of primers labeled with D4
dye which were complementary to the 5′ end of the
designed primers. All the PCR products were designed
>3-bp apart, ranging from 137 bp to 287 bp, so that
they could be distinguished by capillary electrophoresis
analyses. In addition to the 15 genes of interest, each
panel contained 2 housekeeping genes and Kanamycin
RNA (Kan RNA) that served as an external control. Kan
RNA can produce a peak at 325 bp after capillary elec-
trophoresis. Besides that, two sets of primers for SELL
were designed to examine the concordance of the prod-
uct. The primers were synthesized and purified with
PAGE method (TaKaRa, Shiga, Japan). All ordered pri-
mers were diluted to a final concentration of 500 nM
(reverse primers) and 200 nM (forward primers) with
nuclease-free water.
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RNA was diluted to 20–100 ng/μL. The reaction volume
was 10 μL (containing 2 μL of 5×RT buffers, 2.5 μL KanR
RNA, 1 μL reverse primer, 0.5 μL Taq enzyme (Thermo Sci-
entific, Waltham, MA, USA) and 1 μL RNA). In addition to
the primer and Taq enzyme, other reagents were supported
by a Genomelab GeXP Start Kit (Beckman Coulter). The RT
reaction was done in a thermal cycler (Eppendorf) under the
conditions: 1 min at 48°C, 60 min at 42°C, 5 min at 95°C,
and hold at 4°C. Each experiment included a RT-Minus con-
trol and no-template control (NTC) to ensure each peak
provided the expected result. The RT-Minus control was a
no-enzyme reaction to ascertain if the RNA was contami-
nated with DNA. The NTC was a no-template control to
confirm all that reaction reagents were in good condition.
Polymerase chain reaction (PCR)
The reaction volume was 10 μL (2 μL of 5×RT buffers, 2 μL
25 mM MgCl2, 0.35 μL of Thermo-Start DNA Polymerase,
and 1.0 μL of forward primer plex) and 4.65 μL of cDNA
samples from the RT plate. In addition to the primers, other
reagents were supported by Thermo Scientific. The PCR re-
action was done in a thermal cycler (Eppendorf) under the
conditions: 10 min at 95°C, followed by 40 cycles of 30 s at
94°C, 30 s at 55°C, and 1 min at 68°C; hold at 4°C.
Optimization of the concentration of the reverse primer
In the multiplex, there were extremely highly expressed
genes and extremely poorly expressed genes. A dramatic re-
duction in the peak height of highly expressed genes could
help to detect the very poorly expressed genes. A reference
peak that had a median peak height of a multiplex was
selected. All primers that had a peak height higher than the
reference peak were pooled, and a twofold serial dilution
made. An optimal dilution factor was achieved for primers
when the signal strength of the high expressers was reduced
close to that of a reference peak.
Assessment of precision for the GeXP system
Two concentrations of total RNA were included in the
experiment to assess precision. Ten samples were stud-
ied for assessment of intra-assay precision. Five days’
worth of tests were calculated for the inter-assay preci-
sion with starting RNA values of 33 ng and 66 ng.
GeXP fragment and data analyses
The procedure for GeXP fragment and data analyses fol-
lowed the manufacturer instructions. Briefly, PCR pro-
ducts from multiplex reactions were diluted 2:8 in water,
and l μL added to the appropriate wells of a new 96-well
sample microplate. A total of 0.5 μL DNA size standard
400 (GenomeLab GeXP Start Kit; Beckman Coulter) was
added to 38.5 μL of sample loading solution with thor-
ough mixing. The mix solution was assembled and addedto the 96-well sample microplate. The PCR product was
separated based on fragment size by capillary gel electro-
phoresis. The strength of the dye signal was measured
after normalization to KANr RNA using the area under
the curve (AUC). Normalized data were exported to
Microsoft Excel for further analyses.
Serum measurements
A commercially available enzymatic kit (Roche Diagnostics,
Basel Switzerland) was used to measure the serum concen-
tration of glucose, total cholesterol (TC), triglyceride (TG),
high-density lipoprotein cholesterol (HDL-C), and low-
density lipoprotein cholesterol (LDL-C). The inter-assay of
variation (CVs) were <1.9% for glucose, <0.8% for TC,
<2.4% for TG, <1.85% for HDL-C, and <1.20% for LDL-C.
Statistical analyses
Differences in gene expression between groups were
compared using the Mann–Whitney non-parametric
test. Spearman’s correlations were used in study of cor-
relation analyses. P< 0.05 was considered significant.
Results
Single PCR
Each pair of primers was validated by a single PCR (Figure 1
Additional file 3, 4, 5 and 6). All the products were approxi-
mately equal to the designed size, demonstrating that all the
genes were amplified successfully. Kan RNA with 325-bp peak
was detected in all the single PCRs. NTC and RT-Minus con-
trol results showed that all reaction reagents were in good
condition and that the starting RNA was free of DNA.
Optimized results for reverse primers
Our results showed that the reverse primer of four genes
should be diluted and that four genes should be concen-
trated. The appropriate dilutions of the SELL (1), IL1B, ubi-
quitin and ACTB genes were 1:2, 1:4, 1:4 and 1:16,
respectively. The appropriate concentrations of MTHFR,
MCSF and LDLR were twofold and that of TNFalpha was
threefold. Capillary gel electrophoresis results are shown in
Figure 2.
Assessment of precision for the GeXP system
The precision experiment showed that the within-run
and between-run CV values were 3.695–12.537% and
4.405–13.405%, respectively (Additional file 8: Table 3).
Comparison between different products amplified by
different primers for the same gene
To validate the stability and concordance of the GeXP
system, two sets of primers for SELL were designed. The
correlations between the two products were compared
(Figure 3). The correlation efficient between the two
products was 0.780 (P= 0.000).
Figure 1 Single RT-PCR capillary gel electrophoresis of the selected genes. Single RT-PCR capillary gel electrophoresis results of RT-PCR,
NTC, IL1B and ACTB. Other results can be found in Additional file 3, 4, 5 and 6.
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peripheral blood and biochemical items
We carried out the optimized assay to test blood samples
from 50 volunteers. We analyzed the correlation between
gene expression and biochemical items. Three gene expres-
sion levels correlated with serum glucose: TNF-α, MCSF and
HMOX1. Moreover, SELL correlated with TG (Figure 4)
Diagnosis value of the selected gene
We detected a 15-gene expression profile in group C and
the control group with the method described above. The
expressions of IL1B, IL6, IL8, and MCP1 were significantly
different between group C and the control group (Figure 5).Figure 2 Multiplex primer RT-PCR capillary gel electrophoresis results
electrophoresis results after optimization. Multiplex primer RT-PCR capillary
Additional file 7.The combination of the four markers helped to discrimin-
ate patients from controls (Additional file 9: Table 4).Validation of the findings
Another independent set of 15 patients and 15 controls
were used to validate our previous findings. The results
of multiplex primer RT-PCR capillary gel electrophoresis
of four CAD-related genes are shown in Figure 6. The p
values of IL1B, IL6, IL8 and MCP-1 between these two
groups were 0.023, 0.014, 0.021, and 0.048, respectively.
These results further confirmed that IL1B, IL6, IL8 and
MCP-1 were the cytokines most closely related with CAD.before and after optimization. Multiplex primer RT-PCR capillary gel
gel electrophoresis results before optimization can be found in
Figure 3 Comparison between different products amplified by
different primers for SELL.
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values of single genes and four markers
We calculated the positive and negative predictive values
of single genes and four markers .The results were also
validated in independent sample (Additional file 10:
Table 5).Procedure for distinguishing between the CAD state and
normal state using the GeXP system
Therefore, by using the GeXP system, we could distin-
guish a CAD state and a normal state (Figure 7). The
methodology involved the following steps: extraction of
total RNA; RT and PCR reaction setup; single gene RT-
PCR; multiplex primer RT-PCR and optimization; and
statistical analyses. Significant gene panels can be
observed for further study.Figure 4 Correlations between gene expression in peripheral blood a
and glucose (A), TNFalpha and glucose (B), HMOX1 and glucose (C) were 0
between SELL and triglyceride was 0.361 (P< 0.05).Discussion
How to use low amounts of RNA to amplify multiplex
genes in a single reaction is a controversial subject. Real-
time PCR can be used to analyze the expression of one
or a few genes, which is not suitable for multi-PCR de-
tection. Gene chip technology has high throughput, but
it is not suitable for batch-sample detection in clinical
laboratories due to its high cost and low reproducibility.
In recent years, GeXP technology has been used in re-
search in viruses, animals and humans [27-31]. The
multi-PCR assay using GeXP technology has been vali-
dated by real-time PCR [32].
We therefore developed a rapid multi-PCR assay for
analyses of gene expression profiling in peripheral blood.
According to the literature, ACTB and GK are chosen as
reference genes [33-35]. The entire product was equal to
the designed size, which demonstrated that all the target
genes were amplified successfully. This finding showed
that this assay could be used for small samples, had
good reproducibility, and was easy to operate. The
results indicated that this multi-PCR assay might pro-
vide profile analyses of gene expression in peripheral
blood for the risk assessment of CVDs and other
inflammation-related diseases. However, the multiplex
must be optimized individually by attenuation. Further-
more, a lack of precision was present in other processes,
such as RNA extraction, RT, and the PCR reaction. A
standard procedure is needed to reduce the chance of
experimental errors.
Research has shown that high levels of plasma lipids
may promote atherosclerosis [36] and that levels of pro-nd biochemical items. The correlation coefficients between MCSF
.440, 0.449 and 0.538, respectively (P< 0.01). The correlation coefficient
Figure 5 Relative expression of 15 CAD-related genes in the CAD group and control group. Data were normalized to ACTB and GK.
Compared with control group, *P< 0.05.
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of diabetes [37]. The present study also showed that glu-
cose was positively correlated with the expression of
MCSF, HMOX-1 or TNF-α, and that TG was negatively
correlated with SELL gene expression. The relationship
between gene expression and biochemical items merits
further study.
Previous studies indicated that all 15 selected CAD-
related genes might have an important role in theFigure 6 Multiplex primer RT-PCR capillary gel electrophoresis resultspathogenesis of atherosclerosis. However, there were few
reports about the relationship between these genes.
Therefore, we developed a new multiplex PCR assay to
measure them together in one reaction system. We then
compared which genes had the more important roles in
relation to CAD. The results showed that only 4 from 15
analyzed genes were significantly altered when compar-
ing group C with group A. The panel of 4 genes con-
firmed these results in an independent set of tests.of 4 CAD-related genes.
Figure 7 Procedure for distinguishing a CAD state or normal state based on peripheral blood using the GeXP system. The procedure
involved the following steps: extraction of total RNA; RT and PCR reaction setup; single gene RT-PCR; multiplex primer RT-PCR and optimization;
and statistical analyses.
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toms to provide a quantitative assessment of the probabil-
ity of coronary disease [38]. CAD is distinguished by
narrowing of the luminal diameter of vessels. However,
many acute coronary syndromes are caused by plaque dis-
ruption and thrombosis rather than stenosis severity. In-
flammatory mediators such as IL1B, IL8 and MCP-1 are
produced by monocytes and macrophages and they are re-
sponsible to modifying LDL and/or killing bacterial pro-
ducts, whereas IL6 is made within plaques by macrophages
and endothelial cells [12]. Overexpression of these four
genes would be involved in the pathological processes of
the cardiovascular system, and might accelerate the forma-
tion of arterial plaques. Traditional clinical factors are
CAD risk factors, and have not been used to distinguish
the characteristics and compositions of plaques. Hence, we
set up a non-invasive detection method using the expres-
sion patterns of four genes in peripheral blood.
The AUC of the four-gene model was modest at best,
with poor sensitivity and high specificity. Furthermore,the validation results showed the positive and negative
predictive values of the four markers are 71.4% and 68.7%
respectively. These results may be meaningful for the as-
sessment of CAD in laboratory-based studies. Subjects
with symptomatic CAD agree to undergo conventional
angiography, but most individuals without symptomatic
CAD accept conventional angiography reluctantly. Our
model can be used in the assessment of subjects with
asymptomatic CAD. If someone is initially diagnosed as
having CAD, then imaging is necessary as the next step
for the four-gene model. This technology might hold
promise in the identification of patients with non-calcified
plaques, but it has limitations (e.g., insufficient sensitivity).
Conclusions
In summary, a new multiple gene expression analysis sys-
tem has been developed. The primary data indicated that
this system might provide some information for identify-
ing patients with non-calcified plaques. We welcome fur-
ther evaluation of this method in larger study cohorts.
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